Isoray Reports Positive Results In Lung Cancer Study

Shares of tiny Isoray were up 93% today after the company reported 100% survival at 5 years for high-risk lung-cancer patients
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.